NeuroPace (NPCE) Cash from Operations (2020 - 2026)
NeuroPace's (NPCE) quarterly Cash from Operations came in at 5900000.0 in Q1 2026, up 21.33% year-on-year from 4862637.36 in Q1 2025, and down 1280.0% quarter-over-quarter from 500000.0 in Q4 2025.
NeuroPace (NPCE) Cash from Operations (2020 - 2026) Analysis & Trends
NeuroPace's Cash from Operations history runs 7 years deep, the most recent figure standing at 5900000.0 for Q1 2026.
- On a quarterly basis, Cash from Operations rose 21.33% year-over-year to 5900000.0 in Q1 2026; TTM through Mar 2026 was 9400000.0, a 47.49% increase from a year earlier, with the FY2025 full-year figure at 11000000.0, up 38.55% from the prior year.
- Cash from Operations retreated to 5900000.0 in Q1 2026 per NPCE's latest filing, from 500000.0 in the prior quarter.
- Across five years, Cash from Operations topped out at 500000.0 in Q4 2025 and bottomed at 11400000.0 in Q1 2022.
- The 5-year median for Cash from Operations is 4700000.0 (2024), against an average of 5376470.59.
- Across the five-year window, Cash from Operations plunged 93.22% in 2022 and jumped 110.64% in 2025, its largest moves.
- Year by year, Cash from Operations stood at 7874000.0 in 2022, then soared by 58.09% to 3300000.0 in 2023, then slumped by 42.42% to 4700000.0 in 2024, then jumped by 110.64% to 500000.0 in 2025, then tumbled by 1280.0% to 5900000.0 in 2026.
- Per Business Quant, the three latest NPCE Cash from Operations figures stand at 5900000.0 (Q1 2026), 500000.0 (Q4 2025), and 1932000.0 (Q3 2025).
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Cash from Operations (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 201.40 Bn | 194.75 Bn | 6.27 Bn | 1.32 Bn |
| 2 | Stryker | 122.29 Bn | 119.41 Bn | 3.81 Bn | 581.00 Mn |
| 3 | Medtronic | 105.01 Bn | 96.40 Bn | 6.41 Bn | 2.57 Bn |
| 4 | Boston Scientific | 64.81 Bn | 63.59 Bn | 3.61 Bn | 348.00 Mn |
| 5 | Edwards Lifesciences | 55.28 Bn | 51.60 Bn | 1.29 Bn | 43.80 Mn |
| 6 | Dexcom | 29.06 Bn | 27.94 Bn | 750.30 Mn | 525.60 Mn |
| 7 | Koninklijke Philips | 29.02 Bn | 25.93 Bn | 2.07 Bn | 220.10 Mn |
| 8 | GE HealthCare Technologies | 28.27 Bn | 26.20 Bn | 1.98 Bn | 290.00 Mn |
| 9 | Smith & Nephew | 25.80 Bn | 25.22 Bn | - | - |
| 10 | NeuroPace | 494.96 Mn | 440.98 Mn | 18.05 Mn | -5.90 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -5.90 Mn |
| Mar 31, 2026 | -5.90 Mn |
| Dec 31, 2025 | 500,000.00 |
| Dec 31, 2025 | 500,000.00 |
| Sep 30, 2025 | -1.93 Mn |
| Sep 30, 2025 | -1.93 Mn |
| Jun 30, 2025 | -2.07 Mn |
| Jun 30, 2025 | -2.07 Mn |
| Mar 31, 2025 | -7.50 Mn |
| Mar 31, 2025 | -7.50 Mn |
| Dec 31, 2024 | -4.70 Mn |
| Dec 31, 2024 | -4.70 Mn |
| Sep 30, 2024 | -1.77 Mn |
| Sep 30, 2024 | -1.77 Mn |
| Jun 30, 2024 | -3.93 Mn |
| Jun 30, 2024 | -3.93 Mn |
| Mar 31, 2024 | -7.50 Mn |
| Mar 31, 2024 | -7.50 Mn |
| Dec 31, 2023 | -3.30 Mn |
| Dec 31, 2023 | -3.30 Mn |